drugset / Trial / NCT00135681

Immune Dysregulation in Children and Adults With Asthma

NCT00135681

Treatment

Summary

To immunize both normal and asthmatic subjects with a neoantigen, keyhole limpet hemocyanin (KLH) and observe the type of antibody and T cell response that develops.

Timeline

Start
1996-12
Primary completion
Completion
2001-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule
Subject Nedocromil Small molecule

Indications